Product Information
ATROPINE 1% EYE DROPS is a generic product labeled by Apotex Corp., priced at $4.1619 per ML under NDC 60505622602. Its NADAC has been published 238 times since Mar 16, 2022.
FDA first approved this application on Nov 26, 2021. Its Orange Book therapeutic-equivalence code is AT1.
Strength
10 mg/mL
Manufacturer
Apotex Corp.NDC
60505622602
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
ATROPINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA215624FDA Approved
11/26/2021
TE Code
AT1
On Market Since
11/26/2021
Pharmacological Classes
Price Statistics
The NADAC for ATROPINE 1% EYE DROPS has been published 238 times since Mar 16, 2022, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1619 per ML |
|---|---|
| All-time high | $8.4353 (Jun 15, 2022) |
| All-time low | $3.8514 (Jul 22, 2026) |
| 52-week high | $6.6272 |
| 52-week low | $3.8514 |
| Median price | $6.4385 |
| Average price | $6.3152 |
| Largest weekly change | +30.8% (Sep 18, 2024) |
| Weeks tracked | 238 |
| Tracking since | Mar 16, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atropine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATROPINE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ATROPINE 1% EYE DROPS, manufactured by Apotex Corp., is $4.1619 per ML (NDC 60505622602), effective Sep 30, 2026.
How has the price of ATROPINE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ATROPINE 1% EYE DROPS has declined 50.7%. It has been tracked across 238 weekly CMS publications since Mar 16, 2022.
What are the highest and lowest recorded NADAC prices for ATROPINE 1% EYE DROPS?
Since Mar 16, 2022, the NADAC for ATROPINE 1% EYE DROPS has ranged from a low of $3.8514 (Jul 22, 2026) to a high of $8.4353 (Jun 15, 2022), with a median of $6.4385 per ML.
Are there cheaper alternatives to ATROPINE 1% EYE DROPS?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATROPINE 1% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures ATROPINE 1% EYE DROPS?
ATROPINE 1% EYE DROPS (NDC 60505622602) is labeled by Apotex Corp., and CMS classifies it as a generic product.